作者:
Carmen D,Herling [1]
;
Florence,Cymbalista [2]
;
Carolin,Groß-Ophoff-Müller [3]
;
Jasmin,Bahlo [3]
;
Sandra,Robrecht [3]
;
Petra,Langerbeins [3]
;
Anna-Maria,Fink [3]
;
Othman,Al-Sawaf [3]
;
Raymonde,Busch [4]
;
Raphael,Porcher [5]
;
Bruno,Cazin [6]
;
Brigitte,Dreyfus [7]
;
Stefan,Ibach [8]
;
Stéphane,Leprêtre [9]
;
Kirsten,Fischer [3]
;
Florian,Kaiser [10]
;
Barbara,Eichhorst [3]
;
Clemens-Martin,Wentner [11]
;
Manuela A,Hoechstetter [11]
;
Hartmut,Döhner [12]
;
Veronique,Leblond [13]
;
Michael,Kneba [14]
;
Remi,Letestu [2]
;
Sebastian,Böttcher [14]
;
Stephan,Stilgenbauer [15]
;
Michael,Hallek [12]
;
Vincent,Levy [3]
作者单位:
Department I of Internal Medicine and Center of Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. carmen.herling@uk-koeln.de.
[1]
Hopital Avicenne, Assistance Publique-Hopitaux de Paris (AP-HP), Service d'Hematologie Biologique, Bobigny, France.
[2]
Department I of Internal Medicine and Center of Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
[3]
Institute for Medical Statistics and Epidemiology, Technical University, Munich, Germany.
[4]
Center of Clinical Epidemiology, Hopital Hotel-Dieu, Paris, France.
[5]
Service de Maladies du Sang, CHU Claude Huriez, Lille Cedex, France.
[6]
Service d'Hematologie, CHU Poitiers, Poitiers, France.
[7]
WiSP Wissenschaftlicher Service Pharma GmbH, Langenfeld, Germany.
[8]
Inserm Unit U1245 and Department of Hematology, Cancer Centre Henri Becquerel and Normandie University Rouen, Rouen, France.
[9]
Day Clinic Hematology Oncology Palliative Care, Landshut, Germany.
[10]
Department of Hematology Oncology, Immunology, Palliative Medicine, Infectious Diseases and Tropical Medicine, Klinikum Schwabing, Munich, Germany.
[11]
Department of Internal Medicine III, University of Ulm, Ulm, Germany.
[12]
Department of Haematology, Hopital de la Pitie-Salpetriere, Paris, France.
[13]
Second Department of Medicine, University of Schleswig-Holstein, Kiel, Germany.
[14]
Department of Hematology, Oncology and Palliative Medicine, Center for Internal Medicine, University of Rostock, Rostock, Germany.
[15]
Cluster of Excellence on Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.
[16]
Unite de Recherche Clinique, Hopital Avicenne, Bobigny, France.
[17]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);女(雌)性(Female);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);男(雄)性(Male);中年人(Middle Aged);肿瘤, 残余(Neoplasm, Residual);前瞻性研究(Prospective Studies);阿糖腺苷(Vidarabine)
DOI
10.1038/s41375-020-0747-7
PMID
32071431
发布时间
2024-01-14